Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Herrmann

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Clinical Kidney Journal|February 20, 2025
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapyArjunmohan Mohan, Elena-Bianca Barbir, Loren Herrera Hernandez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2018
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysisSandhya Manohar, Panagiotis Kompotiatis, Charat Thongprayoon, et al.
Clinical Kidney Journal|December 4, 2023
Management of hypertension in patients with cancer: challenges and considerationsShubhi Pandey, Amar Kalaria, Kenar D Jhaveri, et al.
Radiology|April 8, 2015
Determination of Single-Kidney Glomerular Filtration Rate in Human Subjects by Using CTSoon Hyo Kwon, Ahmed Saad, Sandra M Herrmann, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 1, 2021
Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary DysfunctionHaixia Qin, Brittany Vlaminck, Itunu Owoyemi, et al.
Kidney International Reports|November 29, 2023
Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung CancerLeticia Sandoval, Yeshwanter Radhakrishnan, Lisa E Vaughan, et al.
Kidney International Reports|October 27, 2025
Complement Inhibition Enables Antivascular Endothelial Growth Factor Receptor Therapy in Renal-Limited Thrombotic MicroangiopathyElena-Bianca Barbir, Abdullah Jalal, Lihong Bu, et al.
American Journal of Nephrology|March 12, 2024
Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related OutcomesArjunmohan Mohan, Pajaree Krisanapan, Supawit Tangpanithandee, et al.
Kidney360|February 24, 2025
Update on the Assessment of GFR in Patients with CancerVerônica T Costa E Silva, Fei Xiong, Lea Mantz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2024
Biomarker-guided infliximab therapy for immune checkpoint inhibitor-induced acute interstitial nephritisElena-Bianca Barbir, Arjunmohan Mohan, Priscilla Koirala, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Clinical Kidney Journal|February 20, 2025
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapyArjunmohan Mohan, Elena-Bianca Barbir, Loren Herrera Hernandez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2018
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysisSandhya Manohar, Panagiotis Kompotiatis, Charat Thongprayoon, et al.
Clinical Kidney Journal|December 4, 2023
Management of hypertension in patients with cancer: challenges and considerationsShubhi Pandey, Amar Kalaria, Kenar D Jhaveri, et al.
Radiology|April 8, 2015
Determination of Single-Kidney Glomerular Filtration Rate in Human Subjects by Using CTSoon Hyo Kwon, Ahmed Saad, Sandra M Herrmann, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 1, 2021
Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary DysfunctionHaixia Qin, Brittany Vlaminck, Itunu Owoyemi, et al.
Kidney International Reports|November 29, 2023
Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung CancerLeticia Sandoval, Yeshwanter Radhakrishnan, Lisa E Vaughan, et al.
Kidney International Reports|October 27, 2025
Complement Inhibition Enables Antivascular Endothelial Growth Factor Receptor Therapy in Renal-Limited Thrombotic MicroangiopathyElena-Bianca Barbir, Abdullah Jalal, Lihong Bu, et al.
American Journal of Nephrology|March 12, 2024
Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related OutcomesArjunmohan Mohan, Pajaree Krisanapan, Supawit Tangpanithandee, et al.
Kidney360|February 24, 2025
Update on the Assessment of GFR in Patients with CancerVerônica T Costa E Silva, Fei Xiong, Lea Mantz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2024
Biomarker-guided infliximab therapy for immune checkpoint inhibitor-induced acute interstitial nephritisElena-Bianca Barbir, Arjunmohan Mohan, Priscilla Koirala, et al.
Pageof 10